Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061779) titled 'Neuroimaging of Brain GABA Concentrations in Athletes with Chronic Pain' on June 3.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Historical
Primary Sponsor:
Institute - Niigata University of Health and Welfare
Condition:
Condition - Chronic pain
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to investigate the resting-state GABA concentration and brain networks in athletes with chronic pain and healthy athletes, thereby elucidating the neural characteristics of athletes with chronic pain and providing fundamental knowledge for exploring more effective therapeutic interventions.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Chronic pain
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - Persistent pain lasting for more than three months
Key exclusion criteria - Individuals with a history of neurological or psychiatric disorders and/or epileptic seizures.
Target Size - 50
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 07 Month 01 Day
Anticipated trial start date - 2026 Year 07 Month 01 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070692
Disclaimer: Curated by HT Syndication.
